M&A Deal Summary

Spectris Acquires SciAps

On July 4, 2024, Spectris acquired medical products company SciAps for 260M USD

Acquisition Highlights
  • This is Spectris’ 1st transaction in the Medical Products sector.
  • This is Spectris’ largest (disclosed) transaction.
  • This is Spectris’ 7th transaction in the United States.
  • This is Spectris’ 1st transaction in Massachusetts.

M&A Deal Summary
Date 2024-07-04
Target SciAps
Sector Medical Products
Buyer(s) Spectris
Deal Type Add-on Acquisition
Deal Value 260M USD

Target

SciAps

Andover, Massachusetts, United States
SciAps specializes in portable analytical instruments for measuring elements, minerals, and compounds using technologies like X-ray Fluorescence (XRF) and Laser-Induced Breakdown Spectroscopy (LIBS). SciAps is based in Andover, Massachusetts.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Spectris

London, United Kingdom
Category Company
Founded 1915
Sector Technology Hardware
Employees7,266
Revenue 1.4B GBP (2023)
DESCRIPTION

Spectris, a supplier of productivity enhancing instrumentation and controls. The Company's products and technologies help customers to improve product quality and performance, improve core manufacturing processes, reduce downtime and wastage and reduce time to market. Spectris operates across four business segments which reflect the applications and industries it serves: Materials Analysis, Test and Measurement, In-line Instrumentation and Industrial Controls. Spectris was founded in 1915 and is based in London, United Kingdom.

DEAL STATS #
Overall 14 of 14
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 13 of 13
State (Massachusetts) 1 of 1
Country (United States) 7 of 7
Year (2024) 1 of 1
Size (of disclosed) 1 of 11
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-04-03 Concept Life Sciences

High Peak, United Kingdom

Concept Life Sciences is a global contract research organization primarily serving the pharmaceutical and life sciences research and development market. With an excellent track record in project execution, delivering tangible value for customers’ IP generation, and a stringent focus on quality. Concept Life Sciences was founded in 1989 and is based in High Peak, United Kingdom.

Sell -
Mergr

Product

Company

Legal